SPL 0.54% 9.3¢ starpharma holdings limited

Ann: FDA Grants SPA Agreement for Phase 3 Recurrent BV Trial, page-7

  1. 4,452 Posts.
    lightbulb Created with Sketch. 582
    I have followed SPL for years and there seems at last to be reason to get in based on the news flow. The realization of a Japanese market is encouraging and now the US could be on the forseeable horizon.

    I see the mathematicians at work, but they tend to trade with the sentiment and the recent sentiment looks to at least be flattened. So I have made a modest entry.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.